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Aberrant cell division is a hallmark of cancer, but the molecular circuitries of this process in tumor cells are
not well understood. Here, we used a high-throughput proteomics screening to identify novel molecular
partners of survivin, an essential regulator of mitosis overexpressed in cancer. We found that survivin
associates with the small GTPase Ran in an evolutionarily conserved recognition in mammalian cells and
Xenopus laevis extracts. This interaction is regulated during the cell cycle, involves Ran-GTP, requires a discrete
binding interface centered on Glu65 in survivin, and is independent of the Ran effector Crm1. Disruption of
a survivin-Ran complex does not affect the assembly of survivin within the chromosomal passenger complex or
its cytosolic accumulation, but it inhibits the delivery of the Ran effector molecule TPX2 to microtubules. In
turn, this results in aberrant mitotic spindle formation and chromosome missegregation in tumor, but not
normal, cells. Therefore, survivin is a novel effector of Ran signaling, and this pathway may be preferentially
exploited for spindle assembly in tumor cells.
Deregulated cell division is a hallmark of cancer (31), which
results in unrestrained cell proliferation, abrogation of cell
cycle checkpoints, and propensity to aneuploidy (27). These
processes hinge on spatial-temporal assembly of a bipolar mi-
totic spindle (23), where microtubules nucleating from dupli-
cated centrosomes or assembled in proximity of mitotic chro-
mosomes “search and capture” chromatids and ultimately
segregate them between daughter cells (46). Reconstitution
experiments in model organisms, particularly cycled Xenopus
laevis extracts, uncovered a pivotal role of the small GTPase
Ran in the mechanism of spindle formation (36). We now
know that a gradient of Ran-GTP assembles on mitotic chro-
mosomes (20), largely through the chromatin-associated activ-
ity of the nucleotide exchange factor RCC1. In turn, this re-
leases Ran effector molecules implicated in spindle formation
(9, 15), including microtubule-stabilizing TPX2 (14), from an
inhibitory interaction with importin / receptors (16, 45).
Depletion of Ran in Xenopus extracts (9) or mammalian cells
(15) or targeting its effector molecules (26, 41, 43) profoundly
impairs spindle formation, causing the appearance of flattened
mitotic spindles, severely depleted of microtubules, and abnor-
mal chromosomal segregation.
Among the regulators of cell division aberrantly overex-
pressed in cancer is survivin (3), a member of the inhibitor of
apoptosis (IAP) gene family with dual roles in suppression of
cell death and control of mitosis (1, 29). The latter has been
linked to a multiplicity of functions, including kinetochore
targeting of the chromosomal passenger complex (22), en-
hancement of Aurora B kinase activity (7), control of kineto-
chore-microtubule interactions for proper chromosomal align-
ment (39), participation in the spindle assembly checkpoint
(11), and regulation of microtubule dynamics for spindle for-
mation (37). Although these functions are essential (32) and
some of them have been conserved evolutionarily from yeasts
to mammals (1, 29), a unifying model for how survivin orches-
trates cell division has not been obtained. This is now a priority
because survivin antagonists are being tested as anticancer
agents in humans (2), and elucidation of the molecular re-
quirements of survivin regulation of mitosis may lead to better
anticancer regimens.
In this study, we took an unbiased approach to identify
molecular regulators of survivin in the control of cell division.
Using high-throughput proteomics screenings in mammalian
cells and Xenopus laevis extracts, we found that survivin phys-
ically associates with Ran and that this interaction is required
to deliver the Ran effector molecule TPX2 to microtubules for
proper spindle formation (36).
MATERIALS AND METHODS
Cells and cell culture. Mouse NIH 3T3 fibroblasts, primary WS-1 human
fibroblasts, and cervical carcinoma HeLa cells were obtained from the American
Tissue Type Collection (ATCC) (Manassas, VA) and maintained in culture
according to the supplier’s specifications. To generate a stable cell line that
expresses survivin, HeLa cells were transduced with a survivin cDNA construct
carrying a carboxyl-terminal hemagglutinin (HA) tag linked to an interleukin 2
receptor subunit surface marker in the pOZ retroviral vector. Transduced cells
were selected by repeated cycles of affinity cell sorting by flow cytometry using
reactivity for interleukin 2 receptor expression. Parental HeLa cells or stable
HeLa-survivin-HA cells (HeLa-SVV) were maintained in a humidified atmo-
sphere containing 5% CO2 at 37°C in Dulbecco’s modified Eagle’s medium
containing 10% heat-inactivated fetal bovine serum, nonessential amino acids,
minimal essential medium, sodium pyruvate, 100 g/ml penicillin, and 100 g/ml
streptomycin (Invitrogen). For cell cycle synchronization, HeLa cells were ar-
rested at the G1/S transition by treatment with 4 mM thymidine (Sigma) for 16 h
at 37°C, released into fresh medium, and analyzed by Western blotting or DNA
content by flow cytometry at increasing time intervals for the first 20 h after
release.
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Antibodies and reagents. The following antibodies to survivin (Novus Biologi-
cals), Ran (Novus Biologicals, Cell Signaling, Santa Cruz Biotechnology), HA
(Santa Cruz Biotechnology), -tubulin (Sigma-Aldrich), Aurora A (Cell Signal-
ing), Borealin (Abgent), Aurora B (Cell Signaling), TPX2 (Novus Biologicals),
RCC1 (Santa Cruz Biotechnology), cyclin B1 (Santa Cruz Biotechnology), or
-actin (Sigma-Aldrich), were used. An antibody to Xenopus survivin was raised
against bacterially expressed, recombinant full-length Xenopus survivin, affinity
purified, and characterized as described previously (8). Restriction enzymes were
purchased from New England BioLabs. Recombinant glutathione S-transferase
(GST)-Rac1 was purchased from Cytoskeleton, Inc.
Plasmid construction and transfections. Full-length cDNAs encoding sur-
vivin or Ran were amplified by reverse transcription-PCR from HeLa cells
and subcloned into HindIII/BamHI sites of pcDNA3.1 or BamHI/XhoI sites
of pGEX-4T-1 vectors carrying an HA tag at the N or C terminus, respec-
tively. Site-directed mutagenesis of survivin or Ran cDNA was carried out by
PCR. Individual mutants were confirmed by DNA sequencing and inserted
into HindIII/BamHI sites of pcDNA3.1 or BamHI/XhoI sites of pGEX-4T-1
vectors carrying HA or FLAG tag at the N or C terminus, respectively. The
various cDNA constructs in pGEX vector were expressed in Escherichia coli
BL21(DE3) strain, grown in LB medium containing ampicillin after induction
with 0.1 mM isopropyl-1-thio-D-galactopyranoside (IPTG) at an optical den-
sity at 600 nm of 0.5. Xenopus survivin was expressed in E. coli BL21 and
affinity purified as described previously (8). Bacterial cultures were harvested
after 3 h, lysed by sonication (10 pulses of 20 s each), and GST fusion proteins
were purified by affinity chromatography on glutathione-Sepharose TM4B
beads (Amersham Biosciences). Proteins were eluted with free glutathione,
and in some experiments, the GST frame was removed by overnight treat-
ment with thrombin followed by immediate neutralization with benzamidine.
The following recombinant mutant proteins were generated (numbers in
parentheses refer to the amino acid sequence): pGEX-Ran(1-45), pGEX-
Ran(1-74), pGEX-Ran(1-125), pGEX-Ran(1-170), pGEX-Ran(171-216),
pGEX-Ran-G19V, pGEX-Ran-T24N, pGEX-Ran-Q69L, pGEX-Survivin(15-
142)-flag, pGEX-Survivin(38-142)-flag, pGEX-Survivin(55-142)-flag, pGEX-
Survivin(71-142)-flag, pGEX-Survivin(81-142)-flag, pGEX-Survivin(88-142),
pGEX-flag-Survivin(1-70), pGEX-flag-Survivin(1-80), pGEX-Survivin(1-87),
pGEX-Survivin(55-70), pcDNA3-HA-survivin-E65A, pcDNA3-survivin-E65A-HA,
pcDNA3-survivin, pcDNA3-survivin-E65A, pcDNA3-HA-survivin(55-142), and
pcDNA3-HA-survivin(71-142), and individual Ala substitutions of each residue
comprised within the survivin sequence Ala55 and Asp70 (A55 to D70). For tran-
sient-transfection experiments, subconfluent cultures of HeLa cells were mixed with
various cDNA constructs in pcDNA3.1 by Lipofectamine (Invitrogen), as recom-
mended by the manufacturer, and harvested after 24 to 48 h at 37°C.
Proteomics screening of survivin-associated molecules in tumor cells. To
identify molecules bound to survivin in vivo, a survivin-HA complex was immu-
noprecipitated from parental HeLa cells or HeLa-SVV cultures using an anti-
body to HA coupled to agarose beads (Sigma-Aldrich) for 4 h under constant
agitation. After washes in 0.1 M KCl-containing buffer (20 mM Tris-HCl [pH
8.0], 5 mM MgCl2, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 0.1%
Tween 20, plus 10 mM -mercaptoethanol), bound proteins were eluted from
HA-agarose beads by the addition of soluble HA peptide (0.2 mg/ml; Sigma-
Aldrich) for 60 min in the same binding buffer. Samples were centrifuged at
20,000 rpm for 1 h, and fractions collected from the top of the centrifugation tube
were separated by high-resolution sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and silver stained. Selected protein bands were
analyzed using an Ettan matrix-assisted laser desorption ionization–time-of-
flight system by Genomine, Inc. (South Korea), and candidate sequences were
matched to the SWISS-PROT and NCBI databases using the search program
ProFound (http://prowl.rockefeller.edu/).
Proteomics screening of survivin-associated molecules in Xenopus egg ex-
tracts. Cytostatic factor (CSF)-arrested egg extracts supplemented with sperm
DNA (100 sperm/l) were activated in the presence of Ca2 for 45 min at 22°C,
and nuclei were analyzed by epifluorescence microscopy to confirm their pro-
gression into S phase. GST-His6 or GST-Xenopus-survivin-His6 was added to the
S-phase extracts (30 g/200 l of extracts), which were cycled back into mitosis
by adding fresh CSF extract (20% initial sample volume) for 60 to 90 min at 22°C.
The appearance of mitotic DNA in the extracts was confirmed by epifluorescence
microscopy. Mitotic egg extracts mixed with recombinant proteins were diluted
four times in binding buffer containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl,
and 5 mM imidazole in the presence of phosphatase (50 mM NaF and 1 mM
Na3VO4) and protease inhibitors (100 M phenylmethylsulfonyl fluoride, 10
g/ml each of leupeptin, pepstatin A, and aprotinin). Survivin-associated pro-
teins were isolated by two-step affinity chromatography as described previously
(8). Survivin protein complexes were isolated from 14 batches of 200-l M-phase
egg extracts, pooled together, and separated by 12% SDS-PAGE. Colloidal blue
(Invitrogen)-stained bands in the survivin eluate, but not GST, were excised from
the gel, and gel slices were washed once in distilled water, followed by two 1-ml
washes in 50% acetonitrile. Liquid was removed from the gel slices with a
27-gauge needle, and samples were frozen at 80°C. Protein bands were ana-
lyzed by mass spectrometry and peptide sequence analysis (Harvard Microchem-
istry Facility, Harvard University, Cambridge, MA).
Spindle assembly in Xenopus egg extracts. CSF-arrested extracts were pre-
pared from unfertilized Xenopus eggs and used to assemble bipolar spindles as
described previously (8). GST-Ran mutant proteins were incubated in CSF-
arrested extracts (final concentration of 2 M) for 60 to 90 min at 22°C. Spindles
and associated chromosomes in the various samples (2l of extracts) were visualized
in the presence of 6 l of Hoechst fixative (60% glycerol, 0.1 mM HEPES [pH 7.5],
10% formaldehyde, and 1 g/ml bisbenzimide) and fluorescence microscopy.
In vitro protein binding assays. For analysis of protein interactions by pull-
down experiments, GST or various GST fusion proteins (15 to 30 g) immobi-
lized on glutathione-Sepharose 4B beads were incubated with purified recombi-
nant proteins (20 or 100 ng) or aliquots of HeLa cell extracts (500 g) for 2 h at
22°C. After five washes (0.5 ml/each) in phosphate-buffered saline (PBS) (pH
7.2), bound proteins were separated by SDS-PAGE and analyzed by Western
blotting. In some experiments, recombinant Ran was incubated with 2 M
purified GDP or GTP for 2 h at 22°C and mixed with increasing concentrations
(100 to 200 ng) of GST or GST-survivin, and bound proteins were analyzed by
Western blotting. For analysis of survivin-Ran protein interactions in Xenopus
egg extracts, purified GST-tagged Ran proteins (2 M) were added to CSF-
arrested extracts, and samples were incubated for 60 min at 22°C.
Subcellular fractionations. Cells were washed in PBS (pH 7.2), suspended in
4 to 5 volumes of cold lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 5 mM EDTA, 50 mM NaF, 0.5% Nonidet P-40, plus protease inhibitors
(Roche Applied Science). After 30-min incubation at 0°C, cell extracts were
cleared by centrifugation at 14,000 rpm for 20 min at 4°C. Nuclear and cytosolic
fractions were prepared from 1  108 HeLa cells using CelLytic NuCLEAR
extraction kit (Sigma-Aldrich), according to the supplier’s instructions. Protein
content was determined using a BCA-200 protein assay kit (Pierce). TPX2
reactivity was used as marker for the nuclear fraction.
Immunoprecipitation and Western blotting. Aliquots (800 g) of cellular or
subcellular extracts were incubated with nonbinding immunoglobulin G (IgG) or
an antibody to Ran or HA prebound to protein A-Sepharose. In some experi-
ments, HeLa cells were incubated in the presence or absence of the Crm1
inhibitor leptomycin B (LMB) (Sigma-Aldrich) (10 nM) for 2 h, harvested, and
incubated with the various primary precipitating antibodies. After 4-h incubation
at 4°C, the immune complexes were washed five times in lysis buffer, and proteins
were separated by SDS-PAGE and analyzed by Western blotting. For these
experiments, proteins (20 to 30 g) were transferred to nitrocellulose mem-
branes, blocked for 1 h at 22°C in 5% nonfat milk in TBST (20 mM Tris-HCl [pH
8.0], 150 mM NaCl, 0.1% Tween 20), and incubated with various primary anti-
bodies for 16 h at 4°C. After washes, samples were incubated with horseradish
peroxidase-conjugated secondary reagents for 1 h at 22°C, and protein bands
were visualized by enhanced chemiluminescence (Amersham). In another series
of experiments, GST or GST-Ran was incubated with extracts from untreated or
LMB-treated HeLa cells, and proteins in bound or unbound fractions were
analyzed by Western blotting. For a control, untreated or LMB-treated HeLa
cells were analyzed for differential subcellular distribution of cyclin B1 by im-
munofluorescence microscopy.
siRNA transfections. Gene silencing by small interfering RNA (siRNA) was
carried out with control (VIII) or survivin-directed (S4) double-stranded RNA
oligonucleotide (50 nmol) as described previously (6). In another series of ex-
periments, WS-1 primary human fibroblasts were transfected with nontargeted
(VIII) or Ran-directed siRNA GAAAUUCGGUGGACUGAGAUU (Dharma-
con), characterized in recent studies (48). Subconfluent cultures were transfected
using Oligofectamine (Invitrogen), harvested after 48 to 96 h at 37°C, and
analyzed by Western blotting; cell cycle analysis of the cultures was performed by
examining DNA content and flow cytometry or, alternatively, by fluorescence
microscopy. For these experiments, cells with disorganized mitotic spindles by
tubulin staining and misaligned chromosomes by 4,6-diamidino-2-phenylindole
(DAPI) reactivity were scored as aberrant mitotic cells.
Microtubule assembly in vitro. Transfected HeLa cells (1  108) were har-
vested by centrifugation at 5,000 rpm for 5 min at 22°C. Cells were washed in PBS
(pH 7.2) and suspended in 2 ml of microtubule stabilization buffer (MSB) at 4°C
after the final wash. MSB consisted of 0.1 M 2-(N-morpholino)ethane sulfonic
acid, 1 mM MgSO4, and 1 mM EGTA (pH 6.6). The mixture was homogenized
with 20 up-and-down strokes in a 1-ml Teflon glass homogenizer at 4°C and then
immediately centrifuged at 12,000 rpm for 5 min at 4°C. The resulting superna-
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tant was then centrifuged at 55,000 rpm for 1 h at 4°C and further incubated with
20 M Taxol and 1 mM GTP for 30 min at 37°C (step 1). The mixture was then
transferred to 4°C for 30 min in the presence of GTP (step 2), and steps 1 and
2 were repeated two or three times. Samples were loaded on 1-ml 10% sucrose
cushion in MSB containing 2 M Taxol and centrifuged at 25,000 rpm for 30 min
at 30°C. The microtubule pellet was suspended in 1 ml of MSB and analyzed by
Western blotting.
Fluorescence microscopy and flow cytometry. HeLa cells under the various
conditions tested were grown on optical-grade glass coverslips, synchronized by
thymidine block for 16 h at 37°C, and fixed 12 h after release (corresponding to
the mitotic transition, as determined by DNA content analysis and flow cytom-
etry) in ice-cold methanol–acetone (1:1) for 5 min at 22°C. Cells were perme-
abilized with 0.1% Triton X-100 for 10 min, blocked in PBS containing 3%
bovine serum albumin and 0.2% Tween 20 for 1 h at 22°C, and labeled with a
primary antibody to -tubulin, TPX2, or HA (1:2000) for 1 h at 22°C, followed
by the addition of Alexa Fluor 594-conjugated secondary reagent (1:1,000) of
appropriate specificity (Molecular Probes). Nuclei were stained with DAPI (6.5
g/ml; Sigma) for 5 min at 22°C. After washes, cells were mounted and analyzed
for nuclear morphology using a fluorescence microscope (Axioplan 2; Zeiss)
equipped with a charge-coupled device camera (Axiocam; Zeiss). Quantification
of TPX2 fluorescence intensity on mitotic spindles and spindle microtubule fibers
of transfected cells was carried out using images imported in Adobe Photoshop
v.7 and analyzed using ImageJ software. An average of 120 mitotic cells was
counted per condition. Spindles in Xenopus extracts were captured with a Roper
CoolSNAP HQ charge-coupled device camera mounted to a Nikon E800 fluo-
rescence microscope and analyzed using Metamorph software v5.0r1 (Universal
Imaging Corp.).
Statistical analysis. Data were analyzed using the unpaired t test on a Graph-
Pad Prism 4.0 software package for Windows (GraphPad Software). A P value of
0.05 was considered statistically significant.
RESULTS
Proteomics screening for novel survivin-associated mole-
cules in tumor cells. To identify novel proteins that associate
with survivin in the regulation of cell division (1, 29), we stably
transfected a carboxyl-terminal HA-tagged wild-type (WT)
survivin cDNA in HeLa cells and selected survivin-expressing
clones using a surface marker by flow cytometry. One cell line,
designated HeLa-SVV, expressed endogenous survivin, as well
as HA-tagged survivin, as determined by Western blotting,
whereas parental HeLa cells expressed only endogenous sur-
vivin (Fig. 1A). Next, we affinity purified survivin-HA com-
plexes from HeLa-SVV cells and identified eluted proteins by
mass spectrometry and matrix-assisted laser desorption ioniza-
tion–time-of-flight analysis. Several protein bands were en-
riched in HeLa SVV eluates compared with parental HeLa
cells, and a silver-stained band of 26 kDa (Fig. 1B) was
identified as the small GTPase, Ran (National Center for Bio-
technology Information Protein Database accession no.
AAC99400) on the basis of the sequences of the following
peptides: SIVFHR, NVPNWHR, LVLVGDGGTGK, and NL
QYYDISAK (16% protein coverage). Accordingly, eluates
from HeLa-SVV extracts contained Ran, survivin, as well as
Smac (Fig. 1C), a molecule known to associate with survivin
(42) by Western blotting. In pulldown experiments, recombi-
nant GST-Ran strongly associated with importin- in HeLa
cell extracts, but not Aurora A (Fig. 1D), in agreement with
previous observations (9, 15). GST-Ran also formed a complex
with survivin in HeLa cell extracts, whereas GST alone was
ineffective (Fig. 1D). Under conditions in which a survivin-Ran
complex was readily detected in HeLa cell extracts, a related
small GTPase, Rac1, did not associate with survivin in pull-
down experiments in vivo (Fig. 1E).
To determine whether a survivin-Ran complex occurred in
vivo, we next carried out immunoprecipitation experiments of
endogenous proteins. Ran immune complexes precipitated
from HeLa cell extracts contained associated survivin, whereas
control IgG immunoprecipitates were negative (Fig. 2A). In
immunoprecipitation experiments from isolated subcellular
fractions, endogenous Ran formed complexes with survivin in
both nuclear and cytosol extracts (Fig. 2B). In contrast, IgG
immunoprecipitates did not contain survivin in the various
subcellular fractions (Fig. 2B). Next, we carried out two exper-
iments to test whether survivin formed a complex with Ran in
vivo independently of Crm1, a known Ran effector that inter-
FIG. 1. Proteomics identification of Ran as a survivin-associated
molecule in tumor cells. (A) Characterization of HeLa-SVV. Parental
cultures or HeLa cells stably transfected with Survivin-HA (HeLa-
SVV) were analyzed by Western blotting with an antibody to survivin
(left panels) or HA (right panel). Reactivity for Smac was used as a
loading control. The position of nonspecific protein bands is indicated
by an asterisk. (B) Identification of Ran as a survivin-associated mol-
ecule. A 26-kDa silver-stained band eluted from survivin-HA beads
(arrowhead) was identified as Ran by mass spectrometry. The posi-
tions of molecular mass markers are indicated to the left of the gel.
(C) Western blotting. Proteins eluted from survivin-HA beads (bound)
or supernatant (unbound) were analyzed by Western blotting.
(D) Pulldown analysis. GST or GST-Ran was incubated with HeLa cell
extracts, and proteins in pellets (bound) or supernatants (unbound)
were analyzed by Western blotting. The bottom panel depicts Coo-
massie blue staining of incubation reaction mixtures. The positions of
GST and GST-Ran are indicated. (E) Specificity of a Ran-survivin
complex. GST-Ran or GST-Rac1 was mixed with HeLa cell extracts,
and proteins in the bound or unbound fractions were analyzed by
Western blotting. The bottom panels depict Coomassie blue staining of
incubation reaction mixtures.
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acts with survivin in nucleocytoplasmic shuttling (24). Treat-
ment of HeLa cells with the Crm1 inhibitor LMB did not affect
the association of endogenous Ran with endogenous survivin
as determined by immunoprecipitation and Western blotting
(Fig. 2C). In contrast, control samples immunoprecipitated
with nonimmune IgG did not contain Ran or survivin in the
presence or absence of LMB (Fig. 2C). Similarly, in pulldown
assays in vivo, GST-Ran indistinguishably associated with endog-
enous survivin in HeLa cell extracts in the presence or absence of
LMB, whereas GST was unreactive (Fig. 2D). Confirming its
Crm1 inhibitory activity, LMB treatment resulted in prominent
nuclear accumulation of cyclin B1 in asynchronous HeLa cells as
seen by immunofluorescence microscopy (Fig. 2E).
Cell cycle requirements of a survivin-Ran complex. Because
survivin expression is regulated by the cell cycle and peaks at
mitosis, we next asked whether a survivin-Ran complex as-
sembled in specific cell cycle phases in vivo. For these ex-
periments, we synchronized HeLa cells at the G1/S boundary
and harvested aliquots of the culture at various time inter-
vals after thymidine release (Fig. 3A). Present at low levels
in interphase cells, survivin expression peaked abruptly at
mitosis, 12 h after thymidine release, and was again down-
regulated with the next G1 phase, 16 to 20 h after release
(Fig. 3B), in agreement with previous observations (1). In
contrast, Ran expression remained constant throughout the
cell cycle in synchronized HeLa cells (Fig. 3B). Ran immu-
noprecipitated from synchronized cultures exhibited a bi-
phasic interaction with survivin, first at 4 h after thymidine
release, thus corresponding to S phase (Fig. 3A), and again
at mitosis, 10 to 12 h after release (Fig. 3C, left panel). In
contrast, control samples immunoprecipitated with nonim-
mune IgG did not contain survivin at any cell cycle phase
(Fig. 3C, right panel). Consistent with this, GST-survivin
associated with endogenous Ran, but not RCC1, in asyn-
chronous HeLa cell extracts, and this interaction was in-
creased in S phase 4 h after thymidine release (Fig. 3D). In
contrast, GST alone did not associate with Ran or RCC1
in asynchronous or S-phase extracts (Fig. 3D).
Conservation of a survivin-Ran interaction in Xenopus laevis
eggs. To determine whether survivin-Ran recognition had been
conserved evolutionarily, we next carried out a proteomics
screening in Xenopus laevis egg extracts (Fig. 4A), a model
extensively used to study mitotic functions. For these experi-
ments, we expressed Xenopus survivin fused to GST and His6,
mixed it with metaphase-arrested Xenopus egg extracts, and
analyzed protein complexes by sequential affinity chromatog-
FIG. 2. Survivin-Ran interaction in vivo. (A) Immunoprecipitation. HeLa cell extracts were immunoprecipitated (IP) with an antibody to Ran
or IgG, and proteins in pellets or supernatants (Sup) were analyzed by Western blotting. (B) Survivin-Ran complexes in isolated subcellular
fractions. Nuclear (N) or cytosolic (C) extracts from HeLa cells were immunoprecipitated (IP) with an antibody to Ran or IgG, and proteins in
pellets or supernatants were analyzed by Western blotting. (C) Leptomycin B treatment. HeLa cells were incubated in the presence () or absence
() of LMB, immunoprecipitated (IP) with an antibody to Ran or IgG, and proteins in pellets or supernatants were analyzed by Western blotting.
(D) In vivo pulldown analysis. GST or GST-Ran was incubated with HeLa cell extracts treated with LMB () or not treated with LMB (), and
proteins in pellets or supernatants were analyzed by Western blotting. The bottom panels depict Coomassie blue staining of GST or GST-Ran
recombinant proteins. (E) Effect of LMB on nucleocytoplasmic shuttling of cyclin B1. HeLa cells were treated with LMB or left untreated and
analyzed by fluorescence microscopy. DNA was stained with DAPI.
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raphy and mass spectrometry (Fig. 4B). Using this protocol,
Xenopus Ran was identified (22% protein coverage based on
peptide sequences) as one of the molecules binding to GST-
survivin, but not GST (Fig. 4B). Accordingly, an antibody to
Ran precipitated survivin from Xenopus egg extracts, whereas
a control IgG was ineffective (Fig. 4C). To determine whether
a survivin-Ran complex in Xenopus egg extracts also assembled
in various cell cycle phases, we harvested aliquots of cycled
extracts during S and M phases, as determined by fluorescence
microscopy of Hoechst-stained chromatin (Fig. 4D). Similar to
the results obtained in mammalian cells, Xenopus survivin im-
munoprecipitated from cycled egg extracts was found in com-
plex with Ran in both the S and M phases of the cell cycle (Fig.
4E). In contrast, IgG immune complexes did not associate with
Ran (Fig. 4E, right panel).
Nucleotide requirement of a survivin-Ran complex. The as-
sociation of Ran with exportin/importin-bound cargos is regu-
lated by its GDP- or GTP-bound state. To test the nucleotide
requirements of a survivin-Ran interaction, we first analyzed
two well-characterized Ran mutants for their ability to associ-
ate with survivin. For these experiments, we mixed recombi-
nant WT or mutant Ran proteins fused to GST with HeLa cell
extracts to allow nucleotide loading and then analyzed their
binding to recombinant survivin. WT Ran associated with re-
combinant survivin, but not GST (Fig. 5A), consistent with the
data reported above. A constitutively active Ran Q69L mutant,
which is unable to hydrolyze GTP, bound considerably more
strongly to survivin than WT Ran did (Fig. 5A). In contrast, a
Ran T24N mutant, which has low binding affinity for GTP and
GDP, nearly completely lost the ability to bind survivin (Fig.
5A). In a second series of experiments, we loaded recombinant
Ran with GDP or GTP in vitro, mixed the reactions with GST
or GST-survivin, and analyzed bound proteins. As shown in
Fig. 5B, GST-survivin bound GTP-loaded Ran with consider-
FIG. 3. Cell cycle-regulated survivin-Ran interaction. (A) DNA content. HeLa cells were synchronized by thymidine block, released in fresh
medium, and analyzed for DNA content at the indicated times (in hours) by propidium iodide staining and flow cytometry. (B) Cell cycle-
dependent expression of survivin. Synchronized HeLa cell extracts were harvested at the indicated times after thymidine release and analyzed by
Western blotting. Asynchronous cells are shown in the lane labeled None. (C) Cell cycle regulation of survivin-Ran interaction. Synchronized HeLa
cell extracts harvested at the indicated times (in hours) after thymidine release were immunoprecipitated (IP) with an antibody to Ran (left panel)
or with IgG (right panel), and associated proteins were analyzed by Western blotting. Asynchronous cells are shown in the lanes labeled None.
(D) In vivo pulldown analysis. HeLa cell extracts from asynchronous (Async) cell cultures or synchronized cultures in S phase (4 h after thymidine
release) were mixed with GST or GST-survivin, and bound proteins were analyzed by Western blotting. The bottom panel depicts Coomassie blue
staining of incubation reaction mixtures. The positions of GST and GST-Ran are indicated.
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ably higher efficiency than GDP-Ran did and in a concentra-
tion-dependent manner (Fig. 5B). In contrast, GST did not
bind Ran in the presence of GDP or GTP (Fig. 5B). Similar
results were obtained in Xenopus extracts. A loss-of-function
Ran T24N mutant failed to promote spindle assembly in
Xenopus extracts (Fig. 5C, top panels), in agreement with pre-
vious observations (36), and weakly associated with survivin
(Fig. 5C, bottom panels). Conversely, a constitutively active
Ran G19V mutant promoted exaggerated spindle formation in
Xenopus extracts (Fig. 5B, top panel), and bound strongly to
survivin (Fig. 5C, bottom panels).
Structure and function of a survivin-Ran complex. To elu-
cidate whether survivin interacted with Ran directly or as a
part of a complex with other Ran-GTP effector molecules, we
next carried out binding studies with recombinant proteins in
vitro. GST-Ran strongly associated with isolated survivin,
whereas GST alone was ineffective (Fig. 6A). This interaction
required the amino-terminal region of Ran, because a frag-
ment comprising residues 1 to 170, but not residues 171 to 216
in Ran, bound survivin in a dose-dependent reaction in vitro
(Fig. 6B). In addition, fragments spanning Ran residues 1 to 74
and 1 to 125 also bound survivin, whereas the most amino-
terminal residues 1 to 45 were ineffective (Fig. 6C). Therefore,
amino acids 45 to 74 in Ran contain a binding site for survivin
(Fig. 6D).
We next used a similar approach to map a Ran binding site
in human survivin in vitro. GST-survivin bound Ran in a con-
centration-dependent manner, whereas GST was unreactive
(Fig. 7A). In addition, fragments of survivin containing amino
acids 1 to 70, 1 to 80 (Fig. 7B), 15 to 142 (Fig. 7C), 38 to 142,
and 55 to 142 (Fig. 7D), also associated with Ran. Conversely,
fragments duplicating the COOH terminal -helix of survivin
between amino acids 71 to 142 and 81 to 142, which have been
implicated in electrostatic interactions with chromosomal pas-
senger proteins Borealin and INCENP (18), did not bind Ran
(Fig. 7B). Therefore, residues 55 to 70 in survivin comprise a
unique binding site for Ran (Fig. 7E). Consistent with this
prediction, a truncated survivin mutant spanning amino acids
55 to 70 retained the ability to bind Ran indistinguishably from
FIG. 4. Proteomics screening for survivin-associated molecules in Xenopus laevis. (A) Protocol for identification of survivin-associated proteins
in cycled Xenopus egg extracts. CSF, cytostatic factor. (B) Survivin-associated molecules in Xenopus egg extracts. GST-Xenopus-survivin-His6 or
GST-His6 was mixed with cycled Xenopus egg extracts, and protein complexes were analyzed by silver staining. The positions of GST, GST-survivin,
and Ran are indicated to the right of the gel. The positions of molecular mass markers are indicated to the left of the gel. (C) Survivin-Ran
complexes in cycled Xenopus extracts. Protein complexes immunoprecipitated (IP) from CSF extracts with an antibody to Ran or IgG were
analyzed by Western blotting. (D) Synchronized Xenopus egg extracts. Aliquots of cycling Xenopus extracts were harvested at the indicated times
representative of S or M phase and stained with Hoechst (left panels). (E) Cell cycle regulation of a survivin-Ran complex in Xenopus egg extracts.
Cycled Xenopus extracts harvested at the indicated time intervals were immunoprecipitated (IP) with an antibody to Xenopus survivin (xSurvivin),
and bound proteins were analyzed by Western blotting. Control immunoprecipitation (IP) reactions were carried out with nonbinding IgG (right
panel).
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WT survivin or a survivin mutant containing amino acids 55 to
142, whereas GST was ineffective (Fig. 7F).
Regulation of TPX2 recognition by a survivin-Ran complex.
To begin testing a role of a survivin-Ran complex in tumor
cells, we first mapped the structural requirements of this in-
teraction in more detail. For these experiments, we mutated to
Ala every residue in the survivin sequence containing amino
acids 55 to 70 (Fig. 7E), expressed the individual point mutants
as GST fusion proteins, and tested their ability to bind Ran in
vitro (Fig. 8A). Only a survivin Glu65Ala (E65A) mutant, thus
outside of a putative nuclear export sequence in survivin (24),
exhibited nearly complete loss of Ran binding in vitro (Fig.
8A). In contrast, Ala mutagenesis of all other amino acids in
the survivin region from amino acids 55 to 70 did not signifi-
cantly affect Ran binding in vitro (Fig. 8A). We next asked
whether mutation of Glu65 in survivin affected the recognition
of other mitotic regulator(s), in particular the chromosomal
passenger proteins (18). For these experiments, we transfected
asynchronous HeLa cells with HA-WT survivin or HA-E65A
survivin mutant and immunoprecipitated aliquots of these cell
extracts with IgG or an antibody to HA. WT survivin immune
complexes contained Ran as determined by Western blotting
(Fig. 8B), whereas immunoprecipitates of survivin E65A mu-
tant were largely devoid of Ran (Fig. 8B), in agreement with
the data presented above. Under these experimental condi-
tions, both WT survivin and survivin E65A mutant associated
with chromosomal passenger proteins Aurora B and Borealin
to comparable levels in vivo (Fig. 8B). In control experiments,
IgG immune complexes did not contain associated molecules,
and Western blotting with an antibody to HA confirmed com-
parable levels of immunoprecipitation of WT or mutant sur-
vivin (Fig. 8B).
Because survivin has been reported to interact with the Ran
target Crm1 in a pathway required for nucleocytoplasmic shut-
tling (24), we also tested whether mutation of Glu65 in survivin
affected its nuclear export. HA-WT survivin and HA-E65A
survivin mutant transfected in HeLa cells exhibited compara-
ble levels of accumulation in isolated cytosolic extracts as de-
termined by Western blotting (Fig. 8C). A potential source of
artifacts in survivin overexpression studies is the addition of
“tag” moieties, which may affect subcellular trafficking and/or
inhibit binding to regulatory molecules (21). To rule out this
possibility, we transfected untagged WT survivin or survivin
E65A mutant in NIH 3T3 cells, which express very low levels of
endogenous survivin, and analyzed isolated subcellular frac-
tions. Similar to the data presented above, both WT and sur-
vivin E65A mutant accumulated at comparable levels in cyto-
solic extracts of NIH 3T3 fibroblasts (Fig. 8D).
Regulation of mitotic spindle assembly by a survivin-Ran
complex. Next, we asked whether a survivin-Ran complex was
required to localize Ran effector molecules during mitosis, and
we focused on TPX2 for its role in spindle formation. In im-
munoprecipitation experiments from HeLa cell extracts, im-
mune complexes of WT survivin contained TPX2 in vivo (Fig.
8E). This interaction was readily detected in asynchronous
culture, and significantly increased in cells synchronized at
mitosis (Fig. 8E). In contrast, immune complexes of survivin
E65A mutant, which has lost the ability to bind Ran, did not
contain TPX2 in asynchronous or mitotic cell extracts, and IgG
immune complexes were unreactive (Fig. 8E). When analyzed
by fluorescence microscopy, HeLa cells expressing survivin
E65A mutant exhibited multiple mitotic defects, characterized
by short, flattened mitotic spindles and grossly abnormal chro-
mosome congression (Fig. 8F).
FIG. 5. Survivin recognition of Ran-GTP. (A) In vivo pulldown
analysis. WT Ran fused to GST (GST-Ran) or the indicated Ran
mutants fused to GST were mixed with HeLa cell extracts, and bound
proteins were analyzed by Western blotting. The bottom panel depicts
Coomassie blue staining of the incubation reaction mixtures. The po-
sitions of GST and GST-Ran are indicated to the right of the gel.
(B) Nucleotide requirement of survivin-Ran interaction. Recombinant
Ran was incubated with 2 M GDP or GTP, mixed with increasing
concentrations (100 to 200 ng [indicated by the height of the triangle
above the gel]) of GST or GST-survivin, and bound proteins were
analyzed by Western blotting. The bottom panel depicts Coomassie
blue staining of incubation reaction mixtures. The positions of GST
and GST-survivin are indicated to the right of the gel. (C) Xenopus
extract pulldown analysis. Cycled Xenopus extracts were incubated ()
with GST or the indicated GST-Ran mutants and analyzed for spindle
formation by fluorescence microscopy (top panels) or differential bind-
ing to survivin (bottom panels). Western blots with comparable
amounts of added GST or GST-Ran proteins are labeled Input and are
shown at the bottom.
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To determine whether this phenotype was due to mislocal-
ization of TPX2 from the mitotic apparatus, we assembled
microtubules from HeLa cells transfected with WT survivin or
survivin E65A mutant in vitro and looked for potential differ-
ences in TPX2 recruitment. Both WT survivin and survivin
E65A mutant associated with polymerized microtubules to
comparable levels as determined by Western blotting with an
antibody to HA (Fig. 9A). However, while polymerized micro-
tubules from cells expressing WT survivin contained TPX2,
transfection of survivin E65A mutant in HeLa cells almost
completely abolished the recruitment of TPX2 to microtubules
(Fig. 9A). In control experiments, comparable amounts of tu-
bulin were assembled in cells transfected with WT or survivin
E65A mutant (Fig. 9A), thus ruling out the possibility that
modulation of TPX2 reactivity was due to a decrease in mi-
crotubule content. By fluorescence microscopy, synchronized
HeLa cells transfected with WT survivin and harvested at mi-
tosis exhibited bipolar mitotic spindles with a full complement
of microtubules, proper chromosome congression, and strong
reactivity for TPX2 at spindle poles and metaphase spindle
fibers (Fig. 9B), in agreement with previous observations (15).
In contrast, synchronized mitotic cells expressing survivin
E65A mutant exhibited grossly abnormal, flattened mitotic
spindles, with considerably attenuated TPX2 reactivity at spin-
dle poles and microtubule fibers (Fig. 9B and C).
Next, we asked whether acute ablation of survivin by siRNA
reproduced the defect in microtubule localization of TPX2
observed after expression of survivin E65A mutant. Transfec-
tion of a survivin-directed double-stranded RNA oligonucleo-
tide (S4) characterized in previous studies (6) resulted in sig-
nificant reduction of survivin levels in both asynchronous
cultures and HeLa cells synchronized at mitosis compared with
nontargeted siRNA (Fig. 9D). In contrast, siRNA targeting of
survivin did not affect Ran levels in asynchronous or mitotic
HeLa cells (Fig. 9D). Transfection of HeLa cells with control
siRNA did not influence the expression or localization of
TPX2 to the mitotic apparatus as examined by fluorescence
microscopy (Fig. 9E). In contrast, even a partial reduction of
survivin levels by siRNA (Fig. 9D) was sufficient to cause
severe spindle defects, with reduced expression of TPX2 on
spindle poles and metaphase spindle fibers (Fig. 9E and F).
Selectivity of a survivin-Ran functional complex in tumor
cells. To test whether a survivin-Ran complex in the regulation
of spindle formation was preferentially operative in tumor
cells, we acutely ablated Ran expression in WS-1 primary hu-
man fibroblasts. Transfection of these cells with a Ran-directed
siRNA resulted in significant suppression of endogenous Ran
expression 48 and 72 h after treatment, whereas a control,
nontargeted siRNA was without effect (Fig. 10A), in agree-
ment with recent observations (48). Under these experimental
conditions, Ran knockdown in WS-1 fibroblasts was not asso-
ciated with cell cycle defects compared with control transfec-
tants as ascertained by DNA content analysis and flow cytom-
etry (Fig. 10B). At variance with the results obtained with
tumor cell types, normal human fibroblasts acutely silenced for
Ran expression did not exhibit formation of aberrant mitotic
spindles or changes in the expression of TPX2 on the mitotic
apparatus as seen by fluorescence microscopy (Fig. 10C), con-
sistent with a selective role of a Ran-survivin pathway in tumor
cell mitosis (48).
DISCUSSION
In this study, we have shown that survivin associates with the
small GTPase Ran (36) and that this interaction is required for
mitotic spindle formation selectively in tumor cells. Differently
from a canonical model of Ran-GTP signaling centered on the
release of spindle assembly factors from importin / inhibi-
FIG. 6. Identification of a survivin binding site in Ran. (A to C) In vitro pulldown analysis. GST or various GST-Ran proteins were incubated
with recombinant survivin (0, 0.1, or 0.2 g), and bound complexes were analyzed by Western blotting. Various fragments of GST-Ran proteins
were used in panels B and C (fragments of GST-Ran proteins from residues 1 to 170 and 171 to 216 were used in panel B, and fragments from
residues 1 to 45, 1 to 74, 1 to 125, and 1 to 170 were used in panel C). Lanes M, molecular weight markers. The bottom panels depict Coomassie
blue staining of GST or GST-Ran recombinant proteins. (D) Ran binding site. A summary of Ran fragments analyzed for differential binding to
survivin is shown. The ability of the Ran fragments to bind to survivin are shown to the right as follows: , bound to survivin; , did not bind to
survivin.
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tion (14), a survivin-Ran complex serves as a physical scaffold
to help deliver the Ran effector molecule TPX2 (36) to micro-
tubules. Relevant features of the survivin-Ran recognition in-
clude evolutionary conservation in Xenopus laevis extracts,
biphasic cell cycle requirements in S phase and mitosis, inde-
pendence from the Ran target (Crm1), preferential recruit-
ment of Ran-GTP, and a discrete binding interface centered
on Glu65 in survivin, which is separate from the chromosomal
passenger complex-interacting domain.
Although survivin is essential for mitosis (32) and this
pathway has been highly conserved during evolution (28), its
molecular requirements have long remained elusive. In par-
ticular, it has been difficult to reconcile the multiple subcel-
lular localizations of mitotic survivin with a single, unifying
mechanism for its role at cell division (1, 29). Conversely,
the data presented here position survivin in an evolutionary
conserved pathway of mitotic spindle formation. Accord-
ingly, a survivin-Ran complex assembled on microtubules
may help increase the local concentration of the “spindle
assembly factor” TPX2 (15) on the mitotic apparatus, thus
stabilizing microtubules and enhancing spindle formation.
This is in agreement with previous observations of a tight
interaction of TPX2 with polymerized microtubules (47),
and prior evidence linking survivin to increased microtubule
stability (13), direct suppression of microtubule dynamics in
vivo (37), and an evolutionary conserved role in spindle
formation in cycled Xenopus extracts (8). The participation
of survivin in spindle assembly is also consistent with its
function as a chromosomal passenger protein (29). We now
know that not only do these molecules participate in central
spindle positioning and cytokinesis but they also contribute
to a Ran-independent mechanism of chromatin-associated
spindle formation (38). As an indispensable regulator of the
core chromosomal passenger complex, responsible for its
subcellular localization and biochemical assembly (18), sur-
vivin has been shown to enhance the catalytic activity of
Aurora B kinase (7), resulting in inhibitory phosphorylation
of the microtubule-depolymerizing kinesin MCAK (44), and
increased microtubule growth around mitotic chromosomes.
The data presented here also fit well with an expanding
FIG. 7. Identification of a Ran binding site in survivin. (A to D) In vitro pulldown analysis. GST or various GST-survivin proteins were
incubated with recombinant Ran (0.1, 0.2, or 0.4 g), and bound complexes were analyzed by Western blotting. Various fragments of GST-survivin
proteins were used in panels B, C, and D. Fragments of GST-survivin proteins from residues 1 to 70, 71 to 142, 1 to 80, and 81 to 142 were used
in panel B. The amount (0.4 or 0.2 g) of GST-survivin protein in the lanes is indicated by the height of the triangle above the gel in panel B. Lane
M, molecular weight markers. The bottom panels in panels A to D depict Coomassie blue staining of GST or various GST-survivin recombinant
proteins. (E) Survivin binding site. A summary of survivin fragments differentially associating with Ran is shown. The ability of the survivin
fragments to bind to Ran are shown to the right as follows: , bound to Ran; , did not bind to Ran. (F) Survivin A55-D70-Ran interaction. GST
or various GST-survivin constructs (0.1 to 0.2 g [indicated by the height of the triangle above the gel]) were incubated with recombinant Ran,
and bound complexes were analyzed by Western blotting. The bottom panel in panel F depicts Coomassie blue staining of various GST-survivin
recombinant proteins, including the full-length (FL) protein.
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involvement of survivin in Ran-GTP signaling. Recent studies
have shown that survivin associated with the Ran effector
Crm1 and that this interaction contributed to nucleocytoplas-
mic shuttling of survivin for proper kinetochore targeting of
the chromosomal passenger complex (24) and modulation of
antiapoptotic survivin levels in the cytosol (25). At variance
from this paradigm, we have shown here that survivin interacts
with Ran directly in a reaction insensitive to the Crm1 inhibitor
LMB, and domain mapping of this recognition using isolated
recombinant proteins identified Glu65 as critically required for
Ran-GTP binding. This region is physically distinct from an
“atypical” nuclear export sequence that has been proposed to
span residues 89 to 98 in survivin and has been implicated in
Crm1 binding (25), as well as recognition of chromosomal
passenger proteins INCENP and Borealin (18). Accordingly, a
survivin E65A mutant, which failed to associate with Ran in
vitro and in vivo, retained the ability to bind the chromosomal
passenger proteins (18) Aurora B and Borealin and the ability
to accumulate in the cytosol (24), indistinguishably from WT
survivin.
Although Ran signaling provides an essential mechanism
of spindle formation in many organisms (46), it has long
been appreciated that some of its critical downstream fac-
tors, for instance TPX2 and NuMa, have not been conserved
during evolution (17). Whether this reflects a cell- and/or
context-specific mechanism by which diverse Ran effector
molecules are differentially recruited for spindle formation
is currently not known, but it is intriguing that many Ran
targets in mammalian cells also function as cancer genes,
differentially expressed or deregulated in tumors, compared
with normal tissues (40). These include an oncogenic kinase
with transforming potential, Aurora A (12), a microtubule-
associated protein overexpressed in certain cancers, HURP (26,
41), a DNA repair/checkpoint protein complex, BRCA1/BARD1
FIG. 8. Molecular targeting of a survivin-Ran complex results in aberrant mitotic spindles. (A) Ala-scanning mutagenesis. Each residue in the
survivin sequence from A55 to D70 was mutated to Ala, and cDNA constructs encoding the various indicated mutants or wild-type survivin were
expressed as GST fusion proteins and incubated with recombinant Ran, and bound proteins were analyzed by Western blotting. Input, 0.2 g. The
bottom panel depicts Coomassie blue staining of GST or GST-survivin recombinant proteins. (B) Immunoprecipitation. Asynchronous HeLa cells
were transfected with HA-WT survivin (HA-SVV) or HA-survivin E65A mutant (HA-E65A), immunoprecipitated (IP) with IgG or with an
antibody to HA, and proteins in pellets or supernatants were analyzed by Western blotting. (C and D) Cytosolic accumulation. HeLa (C) or NIH
3T3 (D) cells were transfected with the indicated HA-tagged (C) or untagged (D) cDNAs, harvested after 24 or 48 h, and analyzed by Western
blotting. The position of nonspecific protein bands is indicated by an asterisk. (E) Survivin-TPX2 interaction. HeLa cells transfected with WT
HA-survivin or HA-E65A survivin mutant were maintained asynchronously (Async) or were synchronized at mitosis, immunoprecipitated (IP) with
an antibody to HA or with IgG, and the immune complexes were analyzed by Western blotting. IgH, immunoglobulin heavy chain. (F) Spindle
defects. Synchronized HeLa cells transfected with WT survivin or survivin E65A mutant were harvested at mitosis and labeled for tubulin or DNA
(DAPI) (left panels). Spindle defects were quantified by fluorescence microscopy in 10 high-power fields in the bar graph shown at the right. The
means plus standard error of the means (error bars) are shown in the graph.
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with critical roles in genomic integrity (19), and now survivin (this
study), a general regulator of tumor cell viability and prolifera-
tion (1, 29). Here, acute silencing of Ran in primary human
fibroblasts was surprisingly well tolerated and did not result
in cell cycle defects or abnormalities of mitotic spindle for-
mation, in agreement with recent observations (48). Collec-
tively, these data support a model that a Ran-survivin com-
plex may be preferentially, if not exclusively, exploited in
FIG. 9. Survivin-regulated delivery of TPX2 to microtubules. (A) Requirement of survivin for TPX2 delivery to microtubules. Polymerized
microtubules were assembled in vitro from HeLa cell extracts transfected with WT survivin or survivin E65A mutant and analyzed by Western
blotting. (B) Depletion of TPX2 from mitotic spindles. Synchronized HeLa cells transfected with WT survivin or survivin E65A mutant were
harvested at mitosis, stained with the indicated antibodies, and analyzed by fluorescence microscopy. DNA was labeled with DAPI. The merged
images are shown in the panels labeled Merge. (C) Quantification of TPX2 fluorescence intensity in transfected cells. The two values were
significantly different (P 	 0.0001) (n 
 120 mitotic cells) as indicated by the three asterisks. (D) Survivin knockdown analysis. Asynchronous
(Async) HeLa cells or HeLa cells synchronized at mitosis were transfected with nontargeted (Control) or survivin-directed siRNA and analyzed
by Western blotting. (E) TPX2 expression in survivin-depleted cells. Synchronized mitotic HeLa cells transfected with control or survivin-directed
siRNA were stained with the indicated antibodies and analyzed by fluorescence microscopy. DNA was stained with DAPI. The merged images are
shown in the panels labeled Merge. (F) Quantification of TPX2 fluorescence intensity in transfected cells. The two values were significantly
different (P 	 0.037) (n 
 11 to 14 mitotic cells) as indicated by the asterisk.
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tumor cells, as opposed to normal cells. It remains to be
seen whether such differential, “tumor-selective” utilization
of oncoproteins in the Ran pathway contributes to tumori-
genesis in vivo. However, the results of initial gene profiling
experiments with ovarian cancer (33) and experimental
breast cancer (34) seem consistent with this possibility, link-
ing increased Ran expression to unfavorable disease out-
come. Mechanistically, deregulated Ran signaling may favor
increased propensity to aneuploidy (35), in agreement with
Ran playing a role in chromosome positioning (17), loading
of spindle checkpoint proteins (5), and organization of ki-
netochore fibers (4). Consistent with this, the Ran targets
Aurora A and TPX2 were identified in a 70-gene signature
predictive of chromosomal instability and poor outcome in
various cancers (10), and expression of survivin has almost
invariably been linked to aggressive tumor behavior, meta-
static disease, and worse prognosis (2). In this context, ex-
ploitation of survivin as a novel effector of Ran signaling
may be ideally suited to further deregulate spindle assembly
in tumor cells, obliterating mitotic checkpoint(s) (11, 30),
promoting aneuploidy, and antagonizing apoptosis (1) in
response to cell division defects, or antimitotic therapies
(49).
In summary, we have identified a novel, evolutionary con-
served mechanism of Ran-GTP signaling (14) centered on a
physical association with survivin and contributing to spin-
dle formation selectively in tumor cells. For the differential
expression of survivin and other Ran targets in cancer, as
opposed to normal tissues (40), molecular or pharmacologic
antagonists of this pathway may be envisioned as potential
therapeutic approaches to selectively disrupt tumor cell mi-
tosis.
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